These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Natural history of graves' orbitopathy after treatment. Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471 [TBL] [Abstract][Full Text] [Related]
4. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy? Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy and Side Effects of Lateral Orbital Wall Decompression Including the Orbital Rim in Patients with Graves' Orbitopathy]. Horn M; Schittkowski MP Klin Monbl Augenheilkd; 2019 Jan; 236(1):17-24. PubMed ID: 30690696 [TBL] [Abstract][Full Text] [Related]
9. Current and Emerging Treatment Strategies for Graves' Orbitopathy. Genere N; Stan MN Drugs; 2019 Feb; 79(2):109-124. PubMed ID: 30659423 [TBL] [Abstract][Full Text] [Related]
11. Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial. Lanzolla G; Sabini E; Leo M; Menconi F; Rocchi R; Sframeli A; Piaggi P; Nardi M; Marcocci C; Marinò M Lancet Diabetes Endocrinol; 2021 Nov; 9(11):733-742. PubMed ID: 34592164 [TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of different treatment modalities for active, moderate-to-severe Graves' orbitopathy: a systematic review and network meta-analysis. Li H; Yang L; Song Y; Zhao X; Sun C; Zhang L; Zhao H; Pan Y Acta Ophthalmol; 2022 Sep; 100(6):e1189-e1198. PubMed ID: 34918472 [TBL] [Abstract][Full Text] [Related]
13. Modified lateral orbital wall decompression in Graves' orbitopathy using computer-assisted planning. Spalthoff S; Jehn P; Zimmerer R; Rana M; Gellrich NC; Dittmann J Int J Oral Maxillofac Surg; 2018 Feb; 47(2):167-174. PubMed ID: 29096933 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Graves' ophthalmopathy. González-García A; Sales-Sanz M Med Clin (Barc); 2021 Feb; 156(4):180-186. PubMed ID: 33069387 [TBL] [Abstract][Full Text] [Related]
15. Teprotumumab for Graves' orbitopathy and ototoxicity: moving problems from eyes to ears? Bartalena L; Marinò M; Marcocci C; Tanda ML J Endocrinol Invest; 2022 Jul; 45(7):1455-1457. PubMed ID: 35403994 [No Abstract] [Full Text] [Related]
16. [Perioperative treatment for the urgent orbital decompression surgery in a 30-weeks pregnant woman with Graves' orbitopathy]. Guerrero-Domínguez R; López-Herrera-Rodríguez D; Domínguez-Blanco A; Medina-de Moya I; Sánchez-Carrillo F Rev Esp Anestesiol Reanim; 2014; 61(6):342-5. PubMed ID: 23835254 [TBL] [Abstract][Full Text] [Related]
17. Orbital decompression in Graves' orbitopathy: efficacy and safety. Goh MS; McNab AA Intern Med J; 2005 Oct; 35(10):586-91. PubMed ID: 16207257 [TBL] [Abstract][Full Text] [Related]